-
Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Rating of "Hold" from Analysts
ソース: Buzz FX / 14 10 2024 05:16:11 America/New_York
Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Rating of "Hold" from Analysts Written by MarketBeat October 14, 2024 Share Link copied to clipboard. Shares of Fate Therapeutics, Inc. ( NASDAQ:FATE - Get Free Report ) have been given
Read more...